Clovis Oncology Inc. (CLVS: Quote) announced the pricing of its underwritten public offering of 3.75 million shares of its common stock at $20.00 per share, before underwriting discounts and commissions.
In addition, the underwriters have a 30-day option to purchase up to an additional 562,500 shares of common stock from Clovis Oncology to cover over-allotments, if any. The offering is expected to close on April 10, 2012, subject to customary closing conditions.
Click here to receive FREE breaking news email alerts for Clovis Oncology, Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org